You are here

Data science: Q&A with IFoA President John Taylor

John Taylor, new President of the IFoA, shares his views on the ways in which the actuarial world is being affected by the inexorable rise of data science.

John TaylorIt’s been suggested that, in their approach to Big Data, actuaries are ‘the original data scientists’. Could you explain that connection? What, in their essentials, do actuaries have in common with data scientists?

When I heard actuaries described as the original data scientists, I really liked the phrase. It captures the essence of what actuaries have been doing for centuries. If you look back at the pioneers of the profession, they were analysing what at the time were large data sets to do with longevity, trying to find the truth and insight in them, and then extrapolate into the future. Then if you look back to just a decade or two, actuaries did similar things around Stochastic asset models – and, again, trying to make projections into the future. And that’s the essence of what data scientists try to do. The tools and technology used have moved on massively, of course, but the fundamentals of trying to extract truth and insight from data, and then using that to infer something about the future, are the same.

Why are actuaries so well placed to explain data science? And can data scientists learn from actuarial practice?

What actuaries bring is a sense of business context, commercial value, and of what it all means for their client – be it a pension scheme, an insurance company, or indeed the ultimate end-user, the consumer. Having that sense of business context, as an overlay to the raw insights that a data scientist may bring, makes those insights more useable and valuable to the client.

The IFoA plans to launch a data science certification. What will be its scope and what will members who undertake it gain?

There’s an appetite among IFoA members to learn more about data science, and so we are about to launch a certificate in data science, available to all members of the actuarial profession. They’ll be able to choose from a set of five modules that cover disciplines such as data visualisation, Artificial Intelligence and Machine Learning. They can pick and choose from them, and those who complete the set of five will be awarded the certificate. From this, actuaries will get a much greater appreciation of the art of the possible in data science. It may not make them data science practitioners per se, but it will enable those certified to work more closely with data scientists. And the certificate will also have a currency with employers in evidencing the additional learning that actuaries have undertaken.

The traditional fields for actuaries have been insurance and pensions. Now actuaries are appearing in agriculture, healthcare, climate change initiatives, and even ride-sharing app development. How does this reflect the way data science is developing?

Data science is very empowering for actuaries. Not only does it bestow the ability to re-engineer what they do in traditional fields, but it gives them a platform to move into wider fields. The underlying driver behind this is that other industries, that haven’t been so accustomed to dealing with data, are now being deluged with it. And they don’t really quite appreciate how to derive value from it. Bringing-in a profession that’s long been expert in dealing with that data, and getting insight out of it, is a tremendous opportunity for those industries – even some of the creative industries like advertising. The ‘Mad Men’ are being replaced by the ‘Math Men’, as advertising becomes much more data-driven about defining individual segments and offering bespoke propositions – and actuaries are getting involved in that kind of innovation.

You have spoken about the ethical implications of data science. What are the key considerations around this question, where actuaries can bring thought leadership?

Developments in data science are throwing up some challenging ethical issues. That does create an opportunity for a profession with an established code of ethics to step in and try and make a difference. The IFoA is also working with the Royal Statistical Society to bring forward a code of ethics around data science. And we’re working with government and policy-makers to make sure that the evolving policy keeps up-to-date with data science.

‘Data science’ is often referred to in public debate, but definitions of what ‘data science’ actually means seem to change continually. How well understood do you feel the term is?

I’m not sure that ‘data science’ is a terribly well understood phrase, in fact. I was speaking to an actuary about my ambitions for the IFoA to do more in the field of data science, and his retort was ‘That’s great – but we also need to be doing more on Artificial Intelligence’. Well, actually, I was using a definition of data science that encompasses AI, so that demonstrates that there’s a degree of confusion around the term. It’s such a dynamic field that as soon as you try and pin down what it is today, it’s changed tomorrow. So, I’m fairly relaxed that it’s dynamic and evolving term.

What do you believe makes the contribution of the actuarial profession so uniquely valuable to the emergent field of data science?

As professionals immersed in business context, and in understanding the impact companies can have with end-users, actuaries are well-placed to add value and utilises the insights data scientists can generate. Let me give you a couple of examples. I know an actuary who works in insurance, and who is looking at new ways to deliver service to existing clients, and that’s about understanding individual customers at a very small level of detail, and looking for trigger points when they might be receptive to new service offerings. This approach is really transforming the take-up rate for services. Second, I heard a compelling example at a conference, where actuaries working in the field of marketing were taking huge amounts of data from social media, and again, trying to infer which customer segments might be suitable for which offerings – and at what times – and then making them available in almost a test-and-learn environment.

How important will collaboration between actuaries and data scientists be, going forward?

Collaboration is going to be vital both for the IFoA and for individual actuaries. Now, most actuaries will be very familiar to working in multidisciplinary teams, they’ve done that for a long time, but I believe they will increasingly do so alongside data scientists and other technologists. The blend of skills will make those teams very powerful. But it’s important that they are able to speak the same language as one another.

What would you say to actuaries who have forebodings that some data science may prove a future threat to their expertise and livelihoods?

It’s very hard to say what the future will look like in, you know, a hundred years’ time. What I can say is that, for the foreseeable future, I think that there’s a  fantastic opportunity for actuaries because of data science. The fact that data is proliferating in not just traditional industry sectors, but everywhere else, means that there’s a kind of crying-out for a profession that can understand the value of data and make predictions based on that understanding. That’s where the essence of the opportunity is for us, I believe. 

Filter or search events

Start date
E.g., 11/07/2020
End date
E.g., 11/07/2020

Events calendar

  • Spaces available

    This webinar is intended to raise awareness of the shifting landscape of climate liability risk and what it means for actuaries, including how it impacts on their professional and legal duties. Presentations will cover the legal risks around climate change for investment consultants and actuaries advising DB pension schemes as well as consideration of climate risk for insurers.

  • Spaces available

    Climate change risks are likely to become material for many risk management and investment decisions. This will require to incorporate explicitly climate change in the tools used for risk management and investment decisions. At present existing climate change tools are often too crude for decision making.

  • Current Issues in Life Assurance (CILA) Webinar series

    Webinar Series
    15 July 2020 - 3 August 2020

    Spaces available

    CILA is one of the pre-eminent events in the annual 'Life' calendar. Due to COVID-19 we are running the programme as a series of webinars covering topics aimed at practicing life actuaries from life offices, consulting firms and other employers of actuaries and those who work in or advise on, the life assurance market in the UK and Europe.

  • Spaces available

    Current Issues in Life Assurance

    For annuity writers, a key challenge is the need to fund capital-consumptive new business strain (NBS) as a consequence of writing the business intended to fund future distributions.

    Reinsurance, investment strategy and capital provision all have roles to play. Here, we:

  • Spaces available

    Current Issues in Life Assurance

    Mortality in 2020 is now dominated by one thing, although – in our future-focused world – the pandemic is just one of many mortality considerations.  In this session, three well-regarded mortality/longevity specialists provide an overview of:

  • Spaces available

    Because of Covid-19, forecasters predict a severe recession in 2020, followed by a V or U-shaped recovery. This impacts both individuals and companies. However, compared to previous recessions, the impact on banks of higher credit losses should be mitigated to some extent by government actions. 

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series

    This session will provide an overview of the Population Health Management Working Party's research including defining impactability and impactability modelling, discussing some examples of specific modelling approaches, considering the practical challenges across the NHS as well as wider public perception and ethical issues.

  • Spaces available

    Many actuaries consider career opportunities in the Finance and Investment practice area after having started off in more traditional actuarial roles such as valuations, capital management or pricing. This session is aimed at helping actuaries to better understand roles in Finance and Investment and how they can fine tune their skills to pursue such careers.

  • Mortality and Longevity Webinar Series 2020

    Webinar Series
    22 July 2020 - 10 August 2020

    Spaces available

    Due to COVID-19, we are running this programme via a series of webinars commencing 22nd July.

    This webinar series will provide topical and practical updates and discussion on the latest thinking and innovations in mortality and longevity, and is designed to be very accessible to a broad range of experience.

     

  • Spaces available

    Predictive risk assessment and risk stratification models based on postcode-level consumer classification are widely used for life insurance underwriting. However, these are socio-economic models not directly related to health information. Similar to precision medicine, precision life insurance should aim to tailor policy pricing/reserving to the individual health characteristics of each client.

  • Spaces available

    As insurers look towards their internal model calibration process for 2020 final year financials and statutory returns, actuaries need to deal with the complexity of adequately modelling their business in 2020 and beyond. This discussion will look at what poor model selection and calibration could look like – using inappropriate historical data; using incorrect 2020 mortality data; inappropriate stochastic model recalibration (or lack thereof). What about being prudent vs setting a best estimate? How do you allow for tail risks during a tail risk event?  This is the fourth webinar in the Extreme Mortality Events series presented by Chair of the Life Board of the Institute and Faculty of Actuaries, Colin Dutkiewicz. 

  • Spaces available

    This webinar has been re-scheduled from its original date of the 1st July. Although ESG has many buyers across the asset allocation community, from pension funds to sovereign wealth funds, it still hasn’t found its place within the core asset management strategy desks where the money is actually invested. The problem as well as the opportunity is Fixed Income. Plenty of strategies exist for incorporating ESG within Equities, from screening, integration to a combination. ESG has picked up relatively quickly within Equities with rating,indices created using ESG factors. This talk will discuss how we price a quantifiable ESG credit risk premium and make it alpha worthy in a strategy. 

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series

    With the rising prevalence of dementia, how can we manage this risk effectively and can insurance do more? Matt Singleton, Ageing Lead at Swiss Re, will cover these topics and demonstrate how insurance could help people address their concerns.

  • Spaces available

    Current Issues in Life Assurance

    This talk will look at a range of such techniques (e.g. mass lapse risk transfer, contract boundaries, risk margin relief, non-standard longevity risk transfer) that have been applied or considered by UK and EU insurers, and the pros and cons of each.

     

  • Spaces available

    Current Issues in Life Assurance.

    The International Association of Insurance Supervisors announced on 14 November 2019 the adoption of v2.0 of the global Insurance Capital Standard (ICS) which will undergo confidential reporting for 5 years starting from 2020. This session will include specific experiences from Legal and General (L&G) as well as global industry perspectives from EY.

  • Spaces available

    Current Issues in Life Assurance

    This session will cover the PRA supervisory statement on financial impacts related to climate change, industry insights into PRA climate risk business plans, examples climate risk strategy setting out key workstreams and activity steps for successful execution, an overview of a climate risk strategy execution timeline and the future.     

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series. Using new and unique research and data from the UK, US, Sweden and China, this presentation investigates how consumers use the internet through their insurance journey and analyzes the role culture and generation plays in their online behaviour. We use this research to show the online landscape for insurance sales in the UK and suggest ways to shape new products and effectively engage with the consumer who is buying them.

  • Spaces available

    Chief Medical Officer (CMO) for Gen Re Life/Health Research and Development, Dr John O'Brien, will discuss the impacts of Gene Modification for life/health insurance. 

  • Spaces available

    As an industry, it has been important to be able to look to the future to identify the next quantifiable risk. In this session, I will explore some of the less tangible, but none-the-less concerning risks to future health, such as the health risks associated with exposure to pesticides, ingestion of plastic in the food chain, and the hazards of indoor air pollution through exposure to volatile organic compounds.

  • Spaces available

    The working party will help the industry to update and enhance how potential risk from diabetes and excess mortality is considered, including the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes.

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series. Modelling the structure and trends of cancer morbidity risk is important for pricing and reserving in related health insurance fields such as critical illness insurance and care provision. We model the dynamics of cancer incidence over time in different regions in England, using 1981-2016 ONS data. The modelling allows estimation of cancer rates at various age, year, gender and region levels, following a Bayesian setting to account for statistical uncertainty. Our analysis indicates significant regional variation in cancer incidence rates. 

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series. In this talk we will outline the steps Aviva took in pulling together our first large-scale disclosures on the exposure of our business to climate change published in March 2019; in line with the recommendations of the Taskforce on Climate-related Financial Disclosures. After touching on why insurers have such an important role in climate change, we'll cover a brief “how-to” guide for those who have not yet embarked on thinking about these topics before giving a case study of how the learnings from a TCFD disclosure exercise can be applied to investment portfolios.

  • Spaces available

    Part of the Protection, Health and Care Conference 2020 webinar series. 

    The insurance industry currently underwrites customers with diabetes based on a range of factors, medical expertise and various medical studies. The work undertaken by the Diabetes Working Party would help the industry to approach this using current research findings to update and enhance how potential risk from diabetes is considered. This includes the need to understand the underwriting implications as treatments improve, and potentially to develop new products that are tailored to those with diabetes. This webinar will present our latest findings in the management of this important chronic condition which will include research in collaboration with the ARC.